Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study to Evaluate the Use of Cidofovir (an Experimental Drug) for the Treatment of Progressive Multifocal Leukoencephalopathy (PML) in AIDS Patients
This study has been completed.
Study NCT00000945 Information provided by National Institute of Allergy and Infectious Diseases (NIAID)
First Received: November 2, 1999 Last Updated: July 29, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
HIV Infections
Additional conditions recognized in this trial
Acquired Immunodeficiency Syndrome
Immunologic Deficiency Syndromes
Infection
Leukoencephalopathy, Progressive Multifocal
More general conditions related to this trial
Central Nervous System Diseases
Central Nervous System Infections
Central Nervous System Viral Diseases
Demyelinating Diseases
DNA Virus Infections
Encephalitis
Encephalitis, Viral
Immune System Diseases
Lentivirus Infections
Nervous System Diseases
Polyomavirus Infections
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Virus Diseases
Interventions listed in this trial
Cidofovir
Probenecid
More general drug interventions related to this trial
Anti-HIV Agents
Anti-Infective Agents
Anti-Retroviral Agents
Antineoplastic Agents
Antirheumatic Agents
Antiviral Agents
Gout Suppressants
Pharmacologic Actions
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Renal Agents
Therapeutic Uses
Uricosuric Agents
Sponsors listed in this trial
National Institute of Allergy and Infectious Diseases (NIAID)
Back to top of Main Content
